Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF


Primary Symbol: V.BTI.H

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Boomskidon Feb 22, 2023 9:26pm
73 Views
Post# 35299837

RE:RE:RE:RE:RE:RE:RE:RE:Causing Implausible Speculation, With No Responsibilty

RE:RE:RE:RE:RE:RE:RE:RE:Causing Implausible Speculation, With No ResponsibiltyYeah, you've said the "xB3 is junk" stuff many times, zwerp. I know you're frustrated and angry, but you can't back up your contention. 

There are many "proofs" but none larger than that Midatech and especially LT and Armistice want it. It's easily provable that they weren't going after EGF. Also, there was no other reason for Rathjen and Mei Mei going to Biodexa. The Cresence team was slated to look after EGF for Biodexa.

So, I'm 99 and 44/100 percent sure that xB3 is the target, and that people who had access to inside information (Midatech, LT and Armistice) know that it works.

The timeline and events since early 2020 at Bioasis should be investigated.

jd
<< Previous
Bullboard Posts
Next >>